OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - AMGEN | Market Closed - Deutsche Boerse AG 20:35:15 26/06/2024 BST | ||
| 10.18 EUR | -5.30% |
|
| Current month | +14.85% | ||
| 1 month | +13.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 10.18 | -5.30% |
| 25/06/24 | 10.75 | +3.27% |
| 24/06/24 | 10.41 | +5.15% |
| 21/06/24 | 9.9 | +0.92% |
| 20/06/24 | 9.81 | +4.36% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 08:35 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0ZNJ |
| ISIN | DE000SB0ZNJ7 |
| Date issued | 08/06/2020 |
| Strike | 204.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.56 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.82 € |
|---|---|
| Lowest since issue | 1.99 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
